Tiapride
Atypical antipsychotic medication
| Tiapride | |
|---|---|
|
|
Tiapride is an atypical antipsychotic medication primarily used in the treatment of psychosis, dyskinesia, and alcohol withdrawal syndrome. It is known for its selective action on the dopamine D2 and D3 receptors, which contributes to its therapeutic effects.
Pharmacology[edit]
Tiapride is classified as a benzamide derivative and functions as a selective dopamine antagonist. Its primary mechanism of action involves blocking the dopamine D2 and D3 receptors, which are implicated in the regulation of mood and movement. This selective antagonism helps alleviate symptoms of psychosis and movement disorders without the extensive side effects associated with typical antipsychotics.
Clinical Uses[edit]
Tiapride is utilized in various clinical settings, including:
- Psychosis: It is effective in managing symptoms of psychosis, particularly in patients who are sensitive to the side effects of other antipsychotic medications.
- Dyskinesia: Tiapride is used to treat movement disorders such as tardive dyskinesia and Huntington's disease.
- Alcohol Withdrawal Syndrome: It helps in managing symptoms associated with alcohol withdrawal, providing a calming effect without significant sedation.
Side Effects[edit]
While tiapride is generally well-tolerated, it can cause some side effects, including:
Dosage and Administration[edit]
Tiapride is administered orally, and the dosage varies depending on the condition being treated. It is important to adjust the dosage based on the patient's response and tolerance to the medication.
Chemical Properties[edit]

Tiapride is a benzamide derivative with a chemical structure that allows it to selectively bind to dopamine receptors. Its molecular formula is C15H24N2O4S, and it has a molecular weight of 328.43 g/mol.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian